Love Dental in Avondale: Now Accepting New Patients
Love Dental in Avondale, led by Dr. Aryan Abedini, now welcomes new patients with advanced, affordable, and compassionate dental care in a modern setting.
'At Love Dental, we prioritize patient comfort and personalized care.' — Dr. Aryan Abedini
AVONDALE, AZ, UNITED STATES, February 5, 2025 / EINPresswire.com / -- Love Dental, a trusted provider of high-quality and affordable dental care, is excited to announce that it is now accepting new patients at its modern and welcoming clinic in Avondale. Led by Dr. Aryan Abedini, a U.S. Navy veteran and experienced dentist, Love Dental offers a full spectrum of dental services designed to meet the needs of individuals and families in the local community.
Located at 12685 W Indian School Rd, Suite 102, Avondale, AZ, Love Dental specializes in preventive care, restorative dentistry, cosmetic enhancements, Invisalign®, teeth whitening, dentures, emergency dental services, and more. The clinic is dedicated to making dental care accessible, providing flexible payment plans, insurance-friendly policies, and convenient scheduling options—including evening appointments.
'At Love Dental, we prioritize patient comfort and personalized care,' said Dr. Abedini. 'Whether you need a routine cleaning or a complete smile makeover, we are here to provide top-tier treatment in a stress-free environment.'
Why Choose Love Dental?
✔ Now Accepting New Patients – Welcoming individuals and families with open arms!
✔ Modern, State-of-the-Art Office – Designed for comfort, efficiency, and the best possible patient experience.
✔ Experienced & Compassionate Team – Led by Dr. Abedini, who brings extensive experience from both military and civilian dental care.
✔ Advanced Technology – Cutting-edge tools and techniques for precise diagnosis and treatment.
✔ Affordable & Flexible Payment Options – Accepting most insurance plans and offering financing solutions.
✔ Convenient Scheduling – Evening appointments available to accommodate busy schedules.
Love Dental is currently welcoming new patients and encourages Avondale residents to schedule an appointment today. Whether you need a routine check-up or a specialized dental procedure, the team at Love Dental is committed to providing outstanding care tailored to your needs.
For media inquiries, interviews, or further information on Love Dental, please contact:
📍 12685 W Indian School Rd, Suite 102, Avondale, AZ 85392
📧 [email protected]
Dr. Aryan Abedini
Love Dental
+1 623-270-7420
Facebook
X
LinkedIn
Instagram
YouTube
TikTok
Other
Legal Disclaimer:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
a day ago
- Associated Press
Capstan Therapeutics Announces Initiation of Phase 1 Trial of Lead In Vivo CAR-T Therapy, CPTX2309, for Treating Autoimmune Disease
SAN DIEGO--(BUSINESS WIRE)--Jun 11, 2025-- Capstan Therapeutics, Inc. ('Capstan'), a clinical-stage biotechnology company dedicated to advancing in vivo reprogramming of cells through RNA delivery using targeted lipid nanoparticles (tLNP), today announced successful dosing of the first participants in its Phase 1 trial of CPTX2309, Capstan's lead anti-CD19 in vivo CAR-T candidate, for the treatment of B cell-mediated autoimmune disorders. The Phase 1 trial will assess the safety, tolerability, pharmacokinetics, and pharmacodynamic activity (i.e., peripheral B cell depletion and recovery) of CPTX2309 treatment in healthy volunteers at various dose levels. Preclinical studies demonstrated rapid, deep, and transient B cell depletion in blood and tissues, which supported the clinical evaluation of CPTX2309 at the planned dose levels and regimens. 'With CPTX2309, our therapeutic goal is to achieve immune reset through rapid and profound B cell depletion using a transient, tunable, and fully off-the-shelf in vivo CAR-T technology,' said Ramin Farzaneh-Far, M.D., Chief Medical Officer at Capstan. 'The focus on a Phase 1 healthy volunteer population allows us to dose escalate efficiently, and importantly, underscores the potential safety advantages of an approach that does not involve lymphodepletion or permanent CAR integration into the genome. The objective of this trial is to determine a pharmacologically active dose (or doses) that can be advanced into Phase 2 studies to treat patients with autoimmune disease.' About Capstan Therapeutics, Inc. ( ) Capstan is a clinical-stage biotechnology company with a mission to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. Our proprietary CellSeeker™ tLNP platform technology is composed of novel LNPs conjugated with a recombinant protein binder, such as a monoclonal antibody, that deliver an RNA payload capable of reprogramming cells in vivo. Capstan's initial focus is on developing in vivo CAR-T therapies designed to combine the potency of CAR-T therapy with the convenience of an off-the-shelf product for the treatment of autoimmune diseases. For more information, please visit and follow us on LinkedIn. About CPTX2309 CPTX2309 is an investigational in vivo CAR-T therapy designed to target B cell-mediated autoimmune disorders through tunable and dose-dependent levels of CAR expression with a potentially favorable clinical safety profile. Preclinical data have shown that CPTX2309 demonstrates robust in vivo engineering of CD8+ CAR T cells, profound B cell depletion in blood and tissues, and repopulation with predominantly naïve B cells in non-human primates. Capstan is currently conducting a Phase 1 trial for CPTX2309 in healthy volunteers in Australia. View source version on CONTACT: Investors: Miguel Arcinas Senior Vice President of Corporate Development Capstan Therapeutics, Inc. [email protected]: Rhiannon Jeselonis Ten Bridge Communications [email protected] KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: RESEARCH GENETICS CLINICAL TRIALS HEALTH TECHNOLOGY BIOTECHNOLOGY HEALTH PHARMACEUTICAL GENERAL HEALTH SCIENCE SOURCE: Capstan Therapeutics, Inc. Copyright Business Wire 2025. PUB: 06/11/2025 07:30 AM/DISC: 06/11/2025 07:28 AM
Business Wire
3 days ago
- Business Wire
Dove Men+Care Encourages Canadian Dads to Celebrate ‘My Most Important Role' on LinkedIn
TORONTO--(BUSINESS WIRE)--To mark Father's Day, Dove Men+Care invites Canadian Dads and father figures to update their LinkedIn profiles with one of their most meaningful life roles: 'Dad.' Rolling out across Canada, the campaign encourages fathers to recognize and celebrate fatherhood as a full-time role and claim space for it on a platform traditionally reserved for professional milestones. As part of the campaign, Canadian Dads are encouraged to use LinkedIn's 'Add position' feature to reflect their role as a father and join a growing movement of men reshaping the traditional definition of masculinity, identity, and care. Making fatherhood LinkedIn-official, Dove Men+Care sparks a broader conversation that urges men to treat personal milestones with the same importance and visibility as professional ones. 'Too often, men proudly share promotions, but rarely the presence and care they bring at home,' said Divya Singh, General Manager, Personal Care, Unilever Canada. 'With this campaign, we are redefining success to include care and celebrate the powerful role fathers and father figures play beyond the workplace.' To kickstart the movement, Dove Men+Care partnered with Founder/CEO Ross Simmonds, Sports Commentator Donnovan Bennett, Celebrity Chef and TV host Dave Rocco, Innovation Strategist Shawn Kanungo. Each thought leader, known in Canada for their professional achievements, are sharing their personal fatherhood stories alongside custom visuals designed by Toronto-based illustrator Mateusz Napieralski. Canadians are encouraged to download and re-share these custom illustrations along with their own fatherhood update and journey. "When men see fatherhood as a vital part of who they are, it positively shapes their mental health and emotional well-being," said Dr. Andrew Howlett, a Toronto-based Child and Family Psychiatrist, and co-founder of the Fathers' Mental Health Network. "By valuing and supporting active fatherhood, we help dads feel recognized and empowered - building resilient families and healthier communities." As a long-time partner of Dove Men+Care, Dad Central, a national organization that provides research, programming, resources, and a community to support father involvement, is helping amplify the campaign through its extensive community network. The group is also contributing expert insight on the cultural importance of active fatherhood and its long-term impact on society. The campaign runs nationally in the lead-up to Father's Day, encouraging Dads across Canada to take part on LinkedIn. To learn more about Dove Men+Care, visit To find out more about Dad Central visit: About Dove Men+Care Dove Men+Care is the first range of products from Dove developed specially for men. Manufactured by Unilever, the line includes the #1 dermatologist recommended male bar and body wash brand. Launched in 2010, the Dove Men+Care portfolio includes bars, body washes, anti-perspirant/deodorants, and hair care. Dove Men+Care is available nationwide in food, drug, and mass outlet stores. About Unilever Unilever is one of the world's leading suppliers of Beauty & Wellbeing, Personal Care, Home Care, Foods and Ice Cream products, with sales in over 190 countries and products used by 3.4 billion people every day. We have 128,000 employees and generated sales of €60.8 billion in 2024. For more information about Unilever and our brands, please visit About Unilever in North America Unilever is one of the world's leading suppliers of Beauty & Wellbeing, Personal Care, Home Care, Foods and Ice Cream products, with sales in over 190 countries and products used by 3.4 billion people every day. We have 128,000 employees and generated sales of €60.8 billion in 2024. Our leading brands in North America include Dove, Hellmann's, Vaseline, Degree, Axe, TRESemmé, Knorr, Magnum, Ben & Jerry's, Nutrafol, Liquid I.V., Paula's Choice, and Dermalogica. For more information on Unilever U.S. and its brands visit: For more information on Unilever Canada and its brands visit: About Unilever in Canada Unilever is one of the world's leading suppliers of Beauty & Wellbeing, Personal Care, Home Care, Foods and Ice Cream products, with sales in over 190 countries and products used by 3.4 billion people every day. We have 128,000 employees and generated sales of €60.8 billion in 2024. Our leading brands in Canada include Dove, Vaseline, Degree, Axe, SheaMoisture, TRESemmé, Knorr, Hellmann's, Breyers, Magnum, Ben & Jerry's, Liquid I.V., and OLLY. For more information on Unilever Canada and visit: or About Dad Central Dad Central is a national non-profit organization dedicated to supporting and promoting responsible father involvement in Canada. Through evidence-based research, resources, and community programming, Dad Central helps fathers, families, and organizations recognize and strengthen the important role dads play in child development and family well-being. With over two decades of experience, Dad Central works to ensure every child has the opportunity to benefit from an involved and caring father.
Yahoo
6 days ago
- Yahoo
OpenAI CMO to Take Leave Following Breast Cancer Diagnosis
OpenAI Chief Marketing Officer (CMO) Kate Rouch will take a three-month medical leave after announcing today that she has been undergoing chemotherapy for breast cancer since shortly after joining OpenAI in December. In a LinkedIn post, Rouch said her prognosis is excellent and that she plans to fully focus on healing. She added that Meta's former CMO, Gary Briggs, will serve as interim head of marketing during her leave. "Earlier this year-just weeks into my dream job-I was diagnosed with invasive breast cancer. We moved to SF on days' notice for treatment, arriving Super Bowl Sunday," Rouch wrote. "For the past five months, I've been undergoing chemo at UCSF while leading our marketing team. It's been the hardest season of life-for me, my husband, and our two young kids." OpenAI Hires Instacart CEO Fidji Simo as Head of Applications Rouch joined OpenAI in December after serving as Coinbase's CMO. Prior to that she spent over a decade at Meta, rising to vice president and global head of brand and product marketing, where she led marketing for the company's core platforms-including Instagram, WhatsApp, Messenger, and Facebook-and worked alongside Briggs. "Silicon Valley can be sharp-edged-fast, competitive, transactional. But getting sick revealed something deeper," Rouch wrote. "We're not cogs in the same machine-we're waves from the same sea." ADWEEK has reached out to OpenAI for comment.
